FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronald Barrett

Research Profile

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Living Beings

Anatomy

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Stephen D Yanofsky; Emily S Shen; Frank Holden; Erik Whitehorn; Barbara Aguilar; Emily Tate; Christopher P Holmes; Randall A Scheuerman; Derek Maclean; May M Wu; Donald E Frail; Francisco J López; Richard Winneker; Brian J Arey; Ronald W Barrett
Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists.
Kenneth C Cundy; Thamil Annamalai; Lin Bu; Josephine De Vera; Jenny Estrela; Wendy Luo; Payal Shirsat; Allan Torneros; Fenmei Yao; Joan Zou; Ronald W Barrett; Mark A Gallop
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys.
Kenneth C Cundy; Russell Branch; Tania Chernov-Rogan; Tracy Dias; Toño Estrada; Karin Hold; Kerry Koller; Xiaoli Liu; Adam Mann; Matt Panuwat; Stephen P Raillard; Shubhra Upadhyay; Quincey Q Wu; Jia-Ning Xiang; Hui Yan; Noa Zerangue; Cindy X Zhou; Ronald W Barrett; Mark A Gallop
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronald Barrett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Stephen D Yanofsky; Emily S Shen; Frank Holden; Erik Whitehorn; Barbara Aguilar; Emily Tate; Christopher P Holmes; Randall A Scheuerman; Derek Maclean; May M Wu; Donald E Frail; Francisco J López; Richard Winneker; Brian J Arey; Ronald W Barrett
Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists.
The Journal of biological chemistry 2006;281(19):13226-33.
2004: Kenneth C Cundy; Thamil Annamalai; Lin Bu; Josephine De Vera; Jenny Estrela; Wendy Luo; Payal Shirsat; Allan Torneros; Fenmei Yao; Joan Zou; Ronald W Barrett; Mark A Gallop
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys.
The Journal of pharmacology and experimental therapeutics 2004;311(1):324-33.
2004: Kenneth C Cundy; Russell Branch; Tania Chernov-Rogan; Tracy Dias; Toño Estrada; Karin Hold; Kerry Koller; Xiaoli Liu; Adam Mann; Matt Panuwat; Stephen P Raillard; Shubhra Upadhyay; Quincey Q Wu; Jia-Ning Xiang; Hui Yan; Noa Zerangue; Cindy X Zhou; Ronald W Barrett; Mark A Gallop
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters.
The Journal of pharmacology and experimental therapeutics 2004;311(1):315-23.
2004: Derek Maclean; Frank Holden; Ann M Davis; Randall A Scheuerman; Stephen D Yanofsky; Christopher P Holmes; William L Fitch; Ken Tsutsui; Ronald W Barrett; Mark A Gallop
Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library.
Journal of combinatorial chemistry 2004;6(2):196-206.
2003: Thomas F Woiwode; Jill E Haggerty; Rebecca Katz; Mark A Gallop; Ronald W Barrett; William J Dower; Steven E Cwirla
Synthetic compound libraries displayed on the surface of encoded bacteriophage.
Chemistry & biology 2003;10(9):847-58.
2001: Iain Uings; P Balasubramanian; P G McLoughlin; Q Yin; L Dash; A Beresford; S Kearney; Ronald W Barrett; Murray McKinnon; BP England
Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity.
Cytokine 2001;15(1):10-9.
2000: BP England; P Balasubramanian; Iain Uings; S Bethell; M J Chen; PJ Schatz; Q Yin; Y F Chen; Erik Whitehorn; A Tsavaler; C L Martens; Ronald W Barrett; Murray McKinnon
A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(12):6862-7.
1999: C Martens; A Bakker; A Rodriguez; R B Mortensen; Ronald W Barrett
A generic particle-based nonradioactive homogeneous multiplex method for high-throughput screening using microvolume fluorimetry.
Analytical biochemistry 1999;273(1):20-31.
1998: William J Dower; Steven E Cwirla; P Balasubramanian; PJ Schatz; DP Baccanari; Ronald W Barrett
Peptide agonists of the thrombopoietin receptor.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():21-9.
1997: NC Wrighton; P Balasubramanian; FP Barbone; A K Kashyap; Francis X Farrell; Linda Jolliffe; Ronald W Barrett; William J Dower
Increased potency of an erythropoietin peptide mimetic through covalent dimerization.
Nature biotechnology 1997;15(12):1261-5.
1997: D D Sloan; Ronald W Barrett; Emily Tate; BP England
Expression of an epitope tagged human C5a receptor and antibody-mediated immobilization of detergent-solubilized receptor for drug discovery screening.
Protein expression and purification 1997;11(1):119-24.
1997: K J Koller; Erik Whitehorn; Emily Tate; T Ries; B Aguilar; T Chernov-Rogan; Ann M Davis; A Dobbs; M Yen; Ronald W Barrett
A generic method for the production of cell lines expressing high levels of 7-transmembrane receptors.
Analytical biochemistry 1997;250(1):51-60.
1997: Steven E Cwirla; P Balasubramanian; D J Duffin; C R Wagstrom; C M Gates; S C Singer; Ann M Davis; RL Tansik; Larry C Mattheakis; C M Boytos; PJ Schatz; DP Baccanari; NC Wrighton; Ronald W Barrett; William J Dower
Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine.
Science (New York, N.Y.) 1997;276(5319):1696-9.
1997: H Schreuder; C Tardif; S Trump-Kallmeyer; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; T Bowlin; Stephen D Yanofsky; Ronald W Barrett
A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
Nature 1997;386(6621):194-200.
1996: A L Akeson; C W Woods; L C Hsieh; R A Bohnke; B L Ackermann; K Y Chan; J L Robinson; S D Yanofsky; J W Jacobs; Ronald W Barrett; Terry Bowlin
AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.
The Journal of biological chemistry 1996;271(48):30517-23.
1996: N C Wrighton; Francis X Farrell; R Chang; A K Kashyap; FP Barbone; LS Mulcahy; Dana L Johnson; Ronald W Barrett; Linda Jolliffe; William J Dower
Small peptides as potent mimetics of the protein hormone erythropoietin.
Science (New York, N.Y.) 1996;273(5274):458-64.
1996: S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; Steven E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; Terry Bowlin; William J Dower; Ronald W Barrett
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7381-6.
1996: Edoardo Sarubbi; S D Yanofsky; Ronald W Barrett; M Denaro
A cell-free, nonisotopic, high-throughput assay for inhibitors of type-I interleukin-1 receptor.
Analytical biochemistry 1996;237(1):70-5.
1995: E A Whitehorn; E Tate; S D Yanofsky; L Kochersperger; A Davis; R B Mortensen; S Yonkovich; K Bell; William J Dower; Ronald W Barrett
A generic method for expression and use of "tagged" soluble versions of cell surface receptors.
Bio/technology (Nature Publishing Company) 1995;13(11):1215-9.
1995: Sriram Balasubramanian; T Chernov-Rogan; A M Davis; E Whitehorn; E Tate; M P Bell; Gerard Zurawski; Ronald W Barrett
Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits.
International immunology 1995;7(11):1839-49.
1995: H Schreuder; C Tardif; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; Terry Bowlin; S Yanofsky; Ronald W Barrett
Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex.
FEBS letters 1995;373(1):39-40.
1995: H A Schreuder; J M Rondeau; C Tardif; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; Terry Bowlin; S Yanofsky; Ronald W Barrett
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
European journal of biochemistry / FEBS 1995;227(3):838-47.
1994: E M Gordon; Ronald W Barrett; William J Dower; S P Fodor; Mark A Gallop
Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.
Journal of medicinal chemistry 1994;37(10):1385-401.
1994: Mark A Gallop; Ronald W Barrett; William J Dower; S P Fodor; E M Gordon
Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.
Journal of medicinal chemistry 1994;37(9):1233-51.
1993: M C Needels; D G Jones; E H Tate; G L Heinkel; L M Kochersperger; William J Dower; Ronald W Barrett; Mark A Gallop
Generation and screening of an oligonucleotide-encoded synthetic peptide library.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(22):10700-4.
1992: Ronald W Barrett; Steven E Cwirla; M S Ackerman; A M Olson; E A Peters; William J Dower
Selective enrichment and characterization of high affinity ligands from collections of random peptides on filamentous phage.
Analytical biochemistry 1992;204(2):357-64.
1991: B P England; M S Ackerman; Ronald W Barrett
A chimeric D2 dopamine/m1 muscarinic receptor with D2 binding specificity mobilizes intracellular calcium in response to dopamine.
FEBS letters 1991;279(1):87-90.
1990: Steven E Cwirla; E A Peters; Ronald W Barrett; William J Dower
Peptides on phage: a vast library of peptides for identifying ligands.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(16):6378-82.